Important Therapy Provides Six Months Pain Relief with Single Injection CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) announced today that Japan’s Ministry of Health, Labour and Welfare has approved Synvisc ® (hylan G-F 20; 3 x 2 mL), indicated for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback